Buy Female Health Company In Part For Its 3.2% Yield

Female Health Company (FHCO) is usually considered among socially responsible investors, being broadly defined as an investment strategy that seeks to consider both financial return and social good. Even tough the social impact of the company's business has a lot of merit, income-investors also can also benefit from this opportunity. Female Health Company currently has an attractive 3.2% dividend yield, which for a small-cap company is unusual. The Female Health Company is publicly traded on the Nasdaq stock exchange and has a market capitalization of around $250 million. The company manufactures, markets, and sells the FC2 female condom in the United States and internationally. Its primary product is the FC2 female condom, the only currently available product under a woman's control that is approved by the U.S. Food and Drug Administration [FDA], which provides dual protection against unintended pregnancy and sexually transmitted infections, including HIV/AIDS. The company's... Read more

Older articles featuring FHCO: